
CVS Health Corp (CVS) is a publicly traded healthcare plans business based in the US. It opened the day at $86.685 after a previous close of $87.49. During the day the price has varied from a low of $85.46 to a high of $86.97. The latest price was $86.17 (25 minute delay). CVS Health is listed on the NYSE and employs 216,000 staff. All prices are listed in US Dollars.
How to buy shares in CVS Health
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: CVS in this case.
- Research CVS Health shares. The platform should provide the latest information available.
- Buy your CVS Health shares. It's that simple.
What's in this guide?
- Can I buy shares in CVS Health?
- Compare share dealing platforms
- Performance over time
- Is CVS Health stock a buy or sell?
- Are CVS Health shares over-valued?
- Is CVS Health suitable for ethical investing?
- CVS Health shares summary
- Does CVS Health pay a dividend?
- How volatile are CVS Health shares?
- Other common questions
Fees for buying 10x CVS Health shares with popular platforms
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
---|---|---|---|---|
![]() |
£0 | $50 | £3.52 £706.84 total |
Capital at risk |
![]() |
£0 | £250 | £11.72 £715.04 total |
Capital at risk |
![]() |
£0 | £1 | £3.16 £706.48 total |
Capital at risk |
![]() |
£0 | No minimum | £7.03 £710.35 total |
Capital at risk |
![]() |
£0 | £1 | £18.98 £722.30 total |
Capital at risk |
![]() |
£0 | £0.01 | £0.70 £704.02 total |
Capital at risk |
![]() |
£9.99 per month | No minimum | £18.54 £721.86 total |
Capital at risk |
![]() |
£36 per year | £20 | £18.29 £721.61 total |
Capital at risk |
![]() |
£0 | £50 | £3.52 £706.84 total |
Capital at risk |
Full comparison of share dealing platforms
CVS Health share price (NYSE:CVS)
Use our graph to track the performance of CVS stocks over time.CVS Health price performance over time
Historical closes compared with the last close of $86.17
1 week (2023-01-27) | -1.83% |
---|---|
1 month (2023-01-03) | -7.25% |
3 months (2022-11-03) | -11.89% |
6 months (2022-08-03) | -15.00% |
1 year (2022-02-01) | -18.91% |
---|---|
2 years (2021-02-03) | 17.65% |
3 years (2020-02-03) | 28.75% |
5 years (2018-02-02) | 12.71% |
Is it a good time to buy CVS Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
Invest in CVS Health shares with 0% commission
- Start investing from $50
- Pay no stamp duty on UK shares
- Join 30 million users who trust their investments with eToro
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is CVS Health under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
P/E ratio
CVS Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, CVS Health shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PEG ratio
CVS Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3591. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
EBITDA
CVS Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $19.1 billion (£15.6 billion).
The EBITDA is a measure of a CVS Health's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health.
Total ESG risk score
CVS Health's total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health's overall score of 18.73 (as at 01/01/2019) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score
CVS Health's environmental score: 1.92/100
Social score
CVS Health's social score: 9.06/100
Governance score
CVS Health's governance score: 2.75/100
Controversy score
CVS Health's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, CVS Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
CVS Health Corp was last rated for ESG on: 2019-01-01.
Total ESG score | 18.73 |
---|---|
Total ESG percentile | 18.84 |
Environmental score | 1.92 |
Social score | 9.06 |
Governance score | 2.75 |
Level of controversy | 3 |
CVS Health shares at a glance
Open | $86.685 |
---|---|
High | $86.97 |
Low | $85.46 |
Close | $86.17 |
Previous close | $87.49 |
Change | $-1.32 |
Change % | -1.5087% |
Volume | 11,156,391 |
52-week range | $84.82 - $108.626 |
---|---|
50-day moving average | $94.4508 |
200-day moving average | $96.5083 |
Wall St. target price | $116.26 |
PE ratio | 36.9156 |
Dividend yield | $2.15 (2.77%) |
Earnings per share (TTM) | $2.37 |
CVS Health share dividends
Dividend yield: 2.77% of stock value
Forward annual dividend yield: 2.77% of stock value
Dividend payout ratio: 33.61% of net profits
CVS Health has recently paid out dividends equivalent to 2.77% of its share value annually.
CVS Health has paid out, on average, around 33.61% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.77% return on their shares, in the form of dividend payments. In CVS Health's case, that would currently equate to about $2.15 per share.
While CVS Health's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.
CVS Health's most recent dividend payout was on 1 February 2023. The latest dividend was paid out to all shareholders who bought their shares by 19 January 2023 (the "ex-dividend date").
Share price volatility
Over the last 12 months, CVS Health's shares have ranged in value from as little as $84.82 up to $108.626. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health's is 0.6829. This would suggest that CVS Health's shares are less volatile than average (for this exchange).
Shares similar to CVS Health
CVS Health in the news
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
Attorney Generals Of Several States Warn CVS, Walgreens Against Mailing Abortion Medication
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
More guides on Finder
-
How to buy Blue Water Vaccines (BWV) shares in the UK
Ever wondered how to buy shares in Blue Water Vaccines? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Vaccines.
-
How to buy Veru (VERU) shares in the UK
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
-
How to buy C4 Therapeutics (CCCC) shares in the UK
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
-
How to buy Clever Leaves (CLVR) shares in the UK
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
-
How to buy NeuroSense Therapeutics (NRSN) shares in the UK
Ever wondered how to buy shares in NeuroSense Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including NeuroSense Therapeutics.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Bone Biologics (BBLG) shares in the UK
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
-
How to buy Adagio Therapeutics (ADGI) shares in the UK
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
-
How to buy Bolt Biotherapeutics (BOLT) shares in the UK
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
Ask an Expert